Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development
- PMID: 12197632
Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development
Abstract
Creutzfeldt-Jakob disease (CJD), the most important human prion disease, occurs in sporadic, iatrogenic and familial form. Except Slovakia and Israel, the recorded familial cases have never exceeded 10-15%. In the Slovak CJD group 95 out of 136 CJD cases (74.2%) carried a CJD-specific mutation in the prion protein gene (PRNP) at codon 200 (mutation E200K). All CJD(E200K) patients carried a heterozygous E200K mutation within the alelle with methionine at codon 129. No more than 53.7% were typical familial cases. The penetrance of the E200K mutation in 1975-2000 was 59.5%. The distribution of codon 129 polymorphism showed 78.6% of methionine-homozygous and 21.4% of methionine/valine-heterozygous patients. Genetic analysis performed on 278 CJD patient relatives demonstrated the E200K mutation in 97 (34.8%) of healthy relatives tested. The E200K mutation carriers were methionine-homozygous in 64% and methionine/valine-heterozygous in 36%. The relatives without the mutation showed a 54.9% methionine homozygosity, 10.4% valine homozygosity and 34.7% methionine/valine heterozygosity. Analysis ofthe E200K carriers provided evidence that the methionine homozygosity is a CJD risk factor, more efficient in CJD patients than in asymptomatic relatives. Th influence of both the E200K mutation and methionine homozygosity at codon 129 was evident in the duration of the clinical stage of CJD and in the immunoreactivity pattern of PrP resistant to proteases (PrP(res)). In the CJD(E200K) methionine-homozygous patients the mean duration ofthe disease was significantly shorter (3.7 +/- 2.0 months) than in the methionine/valine-heterozygous patients (7.84 +/- 7.3 months). Comparison of the PrP(res) positivity in the cerebellum of familial and sporadic CJD using specific polyclonal and monoclonal antibodies (MAbs) to PrP showed less conspicuous immune reaction in CJD(E200K) cases. Methionine-homozygous CJD patients were characteristic mainly by synaptic pattern of staining, while methionine/valine-heterozygous patients by PrP(res) granules and plaque-like structures. Most of numerous plaque-like PrP(res) deposits were found in sporadic valine/valine-homozygous cases. Potential professional risk was excluded in health facility workers. The percentage of professions related to farming was significantly higher in CJD(E200K) (48%) and sporadic CJD (44%) cases as compared to the employed population (9%).
Similar articles
-
A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein.Ann Neurol. 1999 Jun;45(6):812-6. Ann Neurol. 1999. PMID: 10360778
-
Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease.Acta Neuropathol. 2003 May;105(5):449-54. doi: 10.1007/s00401-002-0664-z. Epub 2003 Jan 28. Acta Neuropathol. 2003. PMID: 12677444
-
Mutation in codon 200 and polymorphism in codon 129 of the prion protein gene in Libyan Jews with Creutzfeldt-Jakob disease.Philos Trans R Soc Lond B Biol Sci. 1994 Mar 29;343(1306):385-90. doi: 10.1098/rstb.1994.0033. Philos Trans R Soc Lond B Biol Sci. 1994. PMID: 7913755
-
[Clinicopathological characteristics of Creutzfeldt-Jakob disease with a PrP V180I mutation and M129V polymorphism on different alleles].Rinsho Shinkeigaku. 1999 Aug;39(8):800-6. Rinsho Shinkeigaku. 1999. PMID: 10586622 Review. Japanese.
-
[Recent advances in the research of Creutzfeldt-Jakob disease (CJD) and Gerstmann-Strüssler syndrome (GSS)].Rinsho Shinkeigaku. 1991 Dec;31(12):1306-8. Rinsho Shinkeigaku. 1991. PMID: 1687809 Review. Japanese.
Cited by
-
Updated global epidemiology atlas of human prion diseases.Front Public Health. 2024 Jun 13;12:1411489. doi: 10.3389/fpubh.2024.1411489. eCollection 2024. Front Public Health. 2024. PMID: 38939567 Free PMC article.
-
Cerebrospinal Fluid Biomarkers in the Diagnosis of Creutzfeldt-Jakob Disease in Slovak Patients: over 10-Year Period Review.Mol Neurobiol. 2017 Oct;54(8):5919-5927. doi: 10.1007/s12035-016-0128-4. Epub 2016 Sep 24. Mol Neurobiol. 2017. PMID: 27665282
-
Clinical aspects of common genetic Creutzfeldt-Jakob disease.Eur J Epidemiol. 2012 Feb;27(2):147-9. doi: 10.1007/s10654-012-9660-3. Epub 2012 Mar 2. Eur J Epidemiol. 2012. PMID: 22382354 Free PMC article. No abstract available.
-
A Corticobasal Syndrome Variant of Familial Creutzfeldt-Jakob Disease with Stroke-Like Onset.Case Rep Neurol Med. 2016;2016:4167391. doi: 10.1155/2016/4167391. Epub 2016 Oct 10. Case Rep Neurol Med. 2016. PMID: 27803826 Free PMC article.
-
Human Prion Disorders: Review of the Current Literature and a Twenty-Year Experience of the National Surveillance Center in the Czech Republic.Diagnostics (Basel). 2021 Oct 1;11(10):1821. doi: 10.3390/diagnostics11101821. Diagnostics (Basel). 2021. PMID: 34679519 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials